Orion
Lauri Louhivuori is a Senior Scientist at Orion Corporation since May 2020, with a rich background in research and academia. Prior experience includes serving as a Postdoctoral Researcher at Karolinska Institutet from March 2016 to May 2020 and holding multiple roles at the University of Helsinki between September 2008 and February 2016, including Acting University Lecturer and Graduate Student. Additionally, Lauri worked as a Research Assistant at the University of Eastern Finland from 2005 to 2007. Lauri Louhivuori holds a Doctor of Philosophy (PhD) in Physiology from the University of Helsinki and a Master's degree in Cell and Molecular Biology from the University of Jyväskylä.
This person is not in the org chart
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.